
Pill-Based Knee Cartilage Repair Moves Closer to Reality
Stanford researchers report in mice that blocking a specific enzyme can restore cartilage thickness in aging knees, hinting that future pills or injections could repair osteoarthritis and reduce the need for knee or hip replacements. The approach reprograms cells to a younger state by inhibiting an enzyme; the same drug has completed phase 1 safety testing in humans and is heading to phase 2b trials for sarcopenia, signaling broader medical potential.












